MA

Manjula Anagani

Active Director Director DIN 03501757
DIN 03501757 First appointment Apr 2011 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 7 active board seats
Past companies 2 historical roles
Total affiliations 9 Since Apr 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Manjula Anagani

Data last updated:

Manjula Anagani is a Director at Vijaya Diagnostic Centre Limited (since 2021), Designated Partner at Suyosha Fertility Centre Llp (since 2025) and Designated Partner at Amicus Speciality Clinics Llp (since 2025), and holds 4 more current directorships. The companies operate in Healthcare, Business Services and Animal Husbandry. The largest current company by reported revenue is Vijaya Diagnostic Centre Limited at ₹700 Cr (FY 2025). Earlier, Manjula Anagani was a Managing Director at Suyosha Healthcare Private Limited (2011–2021) and Director at Prashanthi Centre For Fertility Private Limited (2020).

DIN 03501757
Primary Designation Director
Industry Healthcare
First Appointment 19 Apr 2011
Oldest Company Age 24 yrs
Largest company Vijaya Diagnostic Centre Limited Β· ₹700 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vijaya Diagnostic Centre Limited L85195TG2002PLC039075
Director22 Aug 20212002₹700 Cr (FY 2025)Active
Designated Partner17 Jul 20252025Active
Designated Partner24 Mar 20252025Active
Designated Partner31 Oct 20232023Active
Partner25 Feb 20232022Active
Designated Partner18 Jan 20232023Active
Designated Partner18 Jan 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Suyosha Healthcare Private Limited U85110TG2011PTC073953
Managing Director19 Apr 20112011₹31.95 Cr (FY 2023)Amalgamated
Director17 Mar 20202020₹8.41 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Manjula Anagani

Directorship timeline

Open interactive timeline →
Vijaya Diagnostic Centre Limited
Edhas Ventures Llp
Dr. Manjula Anagani Surgical Center Llp
Suyosha Fertility Centre Llp
Premium access

Shareholding and investment profile for Manjula Anagani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manjula Anagani

Manjula Anagani currently holds 7 directorships: Vijaya Diagnostic Centre Limited (Director, since 22 Aug 2021, revenue β‚Ή700 Cr (FY 2025)); Suyosha Fertility Centre Llp (Designated Partner, since 17 Jul 2025); Amicus Speciality Clinics Llp (Designated Partner, since 24 Mar 2025); Skianav Surgical Planning Llp (Designated Partner, since 31 Oct 2023); Cosmos Green Jadcherla Llp (Partner, since 25 Feb 2023); and 2 more.

Manjula Anagani was first appointed on 19 Apr 2011 as Managing Director at Suyosha Healthcare Private Limited. The most recent appointment on record is 17 Jul 2025 at Suyosha Fertility Centre Llp.

Manjula Anagani held 2 earlier board appointments: Suyosha Healthcare Private Limited (Managing Director, 19 Apr 2011 to 11 May 2021); Prashanthi Centre For Fertility Private Limited (Director, 17 Mar 2020 to 11 Jun 2020).

The current boards of Manjula Anagani's companies include Appala Narasimha Raju Kolukuluri (Vijaya Diagnostic Centre Limited), Dipinder Singh Sekhon (Vijaya Diagnostic Centre Limited), Ravi Shankararamiah (Vijaya Diagnostic Centre Limited), Sasikala Paruchuri Kola (Vijaya Diagnostic Centre Limited), Satyanarayana Murthy Chavali (Vijaya Diagnostic Centre Limited), Sunil Kondapally Chandra (Vijaya Diagnostic Centre Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available